These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of corinfar and finoptin on lipid peroxidation]. Zhuravlev AK; Murashko VV; Kamchatnov PR Klin Med (Mosk); 1988 Apr; 66(4):35-7. PubMed ID: 3398447 [No Abstract] [Full Text] [Related]
23. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction. Hansen JF Eur Heart J; 1986 Oct; 7(10):910-1. PubMed ID: 3792353 [No Abstract] [Full Text] [Related]
28. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy]. Korovina EP Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289 [TBL] [Abstract][Full Text] [Related]
29. Calcium channel blockers. New treatment for cardiovascular disease. Rossi LP; Antman EM Am J Nurs; 1983 Mar; 83(3):382-7. PubMed ID: 6550460 [No Abstract] [Full Text] [Related]
30. [Study of the effects of calcium antagonists on respiration mechanics in patients with occlusive ventilation impairment]. Frank-Piskorska A; Wasek Z; Malinowski R Wiad Lek; 1989 Mar; 42(5):278-83. PubMed ID: 2815744 [TBL] [Abstract][Full Text] [Related]
31. Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group. Schartl M J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S79-81. PubMed ID: 1282620 [No Abstract] [Full Text] [Related]
32. [Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?]. Ennezat PV; Auffray JL; Darchis J; Rousselle M; Gonin X; Aubert JM; Bauchart JJ; Bauters C; Van Belle E; Asseman P Therapie; 2006; 61(3):191-4. PubMed ID: 16989118 [TBL] [Abstract][Full Text] [Related]
36. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease. Just H; Frey M Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172 [TBL] [Abstract][Full Text] [Related]
37. Outcome with calcium channel antagonists after myocardial infarction: a community-based study. Leitch JW; McElduff P; Dobson A; Heller R J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027 [TBL] [Abstract][Full Text] [Related]
38. The comparative effects of calcium channel blockers in an experimental colitis model in rats. Zeytunlu M; Korkut M; Akgün E; Firat O; Aynaci M; Içöz G; Kiliç M; Ersin S; Ozütemiz O Turk J Gastroenterol; 2004 Dec; 15(4):243-9. PubMed ID: 16249979 [TBL] [Abstract][Full Text] [Related]
39. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237 [TBL] [Abstract][Full Text] [Related]